Beyond Valuation

Is BYON undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BYON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BYON ($5.92) is trading below our estimate of fair value ($124.64)

Significantly Below Fair Value: BYON is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BYON?

Key metric: As BYON is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BYON. This is calculated by dividing BYON's market cap by their current revenue.
What is BYON's PS Ratio?
PS Ratio0.2x
SalesUS$1.48b
Market CapUS$282.24m

Price to Sales Ratio vs Peers

How does BYON's PS Ratio compare to its peers?

The above table shows the PS ratio for BYON vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3x
SNBR Sleep Number
0.2x1.4%US$263.3m
HVT Haverty Furniture Companies
0.5x4.0%US$374.2m
BBBY.Q Bed Bath & Beyond
0.01xn/aUS$61.7m
HTLM HomesToLife
11.5xn/aUS$57.6m
BYON Beyond
0.2x7.4%US$282.2m

Price-To-Sales vs Peers: BYON is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (4.1x).


Price to Sales Ratio vs Industry

How does BYON's PS Ratio compare vs other companies in the US Specialty Retail Industry?

43 CompaniesPrice / SalesEstimated GrowthMarket Cap
TA TravelCenters of America
0.1x-0.8%US$1.30b
ODP ODP
0.1x-2.1%US$777.35m
ARKO Arko
0.09x-1.7%US$758.30m
GCO Genesco
0.1x1.9%US$331.04m
BYON 0.2xIndustry Avg. 0.4xNo. of Companies43PS00.61.21.82.43+
43 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BYON is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Specialty Retail industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is BYON's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BYON PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: BYON is expensive based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BYON forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$5.92
US$15.79
+166.7%
64.9%US$36.00US$8.00n/a7
Nov ’25US$6.35
US$14.56
+129.3%
69.4%US$36.00US$6.00n/a8
Oct ’25US$9.19
US$22.50
+144.8%
49.8%US$37.00US$11.00n/a7
Sep ’25US$9.83
US$22.93
+133.3%
47.2%US$37.00US$12.50n/a7
Aug ’25US$10.66
US$23.29
+118.4%
45.1%US$37.00US$14.00n/a7
Jul ’25US$12.96
US$25.50
+96.8%
37.7%US$37.00US$15.00n/a7
Jun ’25US$15.13
US$26.43
+74.7%
32.9%US$37.00US$17.00n/a7
May ’25US$19.69
US$36.13
+83.5%
24.5%US$50.00US$26.00n/a8
Apr ’25US$34.90
US$34.00
-2.6%
23.0%US$45.00US$24.00n/a7
Mar ’25US$33.58
US$32.57
-3.0%
21.2%US$45.00US$24.00n/a7
Feb ’25US$23.00
US$29.00
+26.1%
31.9%US$45.00US$16.00n/a7
Jan ’25US$27.69
US$21.00
-24.2%
16.8%US$25.00US$16.00n/a5
Dec ’24US$21.46
US$23.00
+7.2%
37.5%US$41.00US$16.00n/a6
Nov ’24US$15.26
US$22.50
+47.4%
39.1%US$41.00US$16.00US$6.356
Oct ’24US$15.82
US$38.17
+141.3%
58.8%US$85.00US$19.00US$9.196
Sep ’24US$26.54
US$46.40
+74.8%
45.0%US$87.00US$28.00US$9.835
Aug ’24US$37.06
US$47.40
+27.9%
42.4%US$87.00US$33.00US$10.665
Jul ’24US$32.57
US$40.50
+24.3%
64.8%US$92.00US$20.00US$12.965
Jun ’24US$18.81
US$35.70
+89.8%
79.1%US$92.00US$19.00US$15.135
May ’24US$19.61
US$35.70
+82.0%
79.1%US$92.00US$19.00US$19.695
Apr ’24US$20.27
US$37.50
+85.0%
71.8%US$91.00US$20.00US$34.905
Mar ’24US$18.76
US$34.42
+83.5%
74.2%US$91.00US$19.00US$33.586
Feb ’24US$24.38
US$44.20
+81.3%
63.2%US$98.00US$20.00US$23.005
Jan ’24US$19.36
US$46.20
+138.6%
57.2%US$98.00US$26.00US$27.695
Dec ’23US$26.24
US$46.20
+76.1%
57.2%US$98.00US$26.00US$21.465
Nov ’23US$23.02
US$46.20
+100.7%
57.2%US$98.00US$26.00US$15.265

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies